The DOI matches its Crossref record; 40 of the 46 references it cites were found in a registry or an index.
Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease
Open accessAbstract
Importance: The activity of lipoprotein lipase (LPL) is the rate-determining step in clearing triglyceride-rich lipoproteins from the circulation. Mutations that damage the LPL gene (LPL) lead to lifelong deficiency in enzymatic activity and can provide insight into the relationship of LPL to human disease. Objective: To determine whether rare and/or common variants in LPL are associated with early-onset coronary artery disease (CAD). Design, Setting, and Participants: In a cross-sectional study, LPL was sequenced in 10 CAD case-control cohorts of the multinational Myocardial Infarction Genetics Consortium and a nested CAD case-control cohort of the Geisinger Health System DiscovEHR cohort between 2010 and 2015. Common variants were genotyped in up to 305 699 individuals of the Global Lipids Genetics Consortium and up to 120 600 individuals of the CARDIoGRAM Exome Consortium between 2012 and 2014. Study-specific estimates were pooled via meta-analysis. Exposures: Rare damaging mutations in LPL included loss-of-function variants and missense variants annotated as pathogenic in a human genetics database or predicted to be damaging by computer prediction algorithms trained to identify mutations that impair protein function. Common variants in the LPL gene region included those independently associated with circulating triglyceride levels. Main Outcomes and Measures: Circulating lipid levels and CAD. Results: Among 46 891 individuals with LPL gene sequencing data available, the mean (SD) age was 50 (12.6) years and 51% were female. A total of 188 participants (0.40%; 95% CI, 0.35%-0.46%) carried a damaging mutation in LPL, including 105 of 32 646 control participants (0.32%) and 83 of 14 245 participants with early-onset CAD (0.58%). Compared with 46 703 noncarriers, the 188 heterozygous carriers of an LPL damaging mutation displayed higher plasma triglyceride levels (19.6 mg/dL; 95% CI, 4.6-34.6 mg/dL) and higher odds of CAD (odds ratio = 1.84; 95% CI, 1.35-2.51; P < .001). An analysis of 6 common LPL variants resulted in an odds ratio for CAD of 1.51 (95% CI, 1.39-1.64; P = 1.1 × 10-22) per 1-SD increase in triglycerides. Conclusions and Relevance: The presence of rare damaging mutations in LPL was significantly associated with higher triglyceride levels and presence of coronary artery disease. However, further research is needed to assess whether there are causal mechanisms by which heterozygous lipoprotein lipase deficiency could lead to coronary artery disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Observational cohorts demonstrate that higher TG and remnant cholesterol predict cardiovascular events independently of LDL-C, while Mendelian randomization analyses confirm a causal relationship between lifelong TRL elevation and ASCVD.”
From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“while rare, loss-of-function mutations in the APOC3, ANGPTL3, and ANGPTL4 genes, which encode for natural inhibitors of LPL, are associated with lower triglyceride levels and a corresponding lower risk of cardiovascular disease.[9][10][11][12][13]”
From Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease (2019) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“rare loss-of-function mutations in the lipoprotein lipase (LPL) gene are associated with higher plasma triglyceride levels and a higher risk of cardiovascular disease”
From Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease (2019) · cites this paper as [11]
Experimental — accuracy not yet measuredIn the citing paper
“Mendelian randomization studies focused on variants in the genes encoding apoAV, apoCIII, lipoprotein lipase (LpL) and the angiopoietin-like proteins 3, 4, and 8 (ANGPTL3, ANGPTL4, and ANGPTL8) have been highly informative.29–35”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Self-citationPrincipal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Self-citationMendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
ClinVar: public archive of relationships among sequence variation and human phenotype
Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1113 · Cited by 3,516
Genomewide Association Analysis of Coronary Artery Disease
Samani, N. J., Erdmann, J., Hall, A. S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R. J., Meitinger, T., Braund, P., Wichmann, H.-E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072366 · Cited by 2,044
Self-citationGenetic Investigation of ANthropometric Traits (GIANT) Consortium, Yang, J., DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Ferreira, T., Morris, A. P., Medland, S. E., Madden, P. A. F., Heath, A. C., Martin, N. G., Montgomery, G. W., et al. (2012) · Nature Genetics · doi:10.1038/ng.2213 · Cited by 1,712
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671
Self-citationA Common Allele on Chromosome 9 Associated with Coronary Heart Disease
McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D. R., Hinds, D. A., Pennacchio, L. A., Tybjaerg-Hansen, A., Folsom, A. R., et al. (2007) · Science · doi:10.1126/science.1142447 · Cited by 1,587
Self-citation
Flagged first, then by citations
6 of the 46 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [2]Brunzell JD Deeb SS Familial lipoprotein lipase deficiency, apo CII deficiency and hepatic lipase deficiency Scriver CR Beaudet AI Sly WS Valle D The metabolic and molecular basis of inherited disease 8 New York McGraw-Hill 2000 2789 816
Cited by
Sorted by citations
The changing landscape of atherosclerosis
Libby, P. (2021) · Nature · doi:10.1038/s41586-021-03392-8 · Cited by 2,873
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
Dewey, F. E., Gusarova, V., Dunbar, R. L., O’Dushlaine, C., Schurmann, C., Gottesman, O., McCarthy, S., Van Hout, C. V., Bruse, S., Dansky, H. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612790 · Cited by 885
Self-citationFerence, B. A., Kastelein, J. J. P., Ray, K. K., Ginsberg, H. N., Chapman, M. J., Packard, C. J., Laufs, U., Oliver-Williams, C., Wood, A. M., Butterworth, A. S., et al. (2019) · JAMA · doi:10.1001/jama.2018.20045 · Cited by 703
Self-citationGenetics of coronary artery disease: discovery, biology and clinical translation
Khera, A. V., & Kathiresan, S. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.160 · Cited by 659
Self-citationGenetics of blood lipids among ∼300,000 multi-ethnic participants of the Million Veteran Program
Global Lipids Genetics Consortium, Klarin, D., Myocardial Infarction Genetics (MIGen) Consortium, The Geisinger-Regeneron DiscovEHR Collaboration, Program, T. V. M. V., Damrauer, S. M., Cho, K., Sun, Y. V., Teslovich, T. M., Honerlaw, J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0222-9 · Cited by 625
Self-citationPolygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
Fahed, A. C., Wang, M., Homburger, J. R., Patel, A. P., Bick, A. G., Neben, C. L., Lai, C., Brockman, D., Philippakis, A., Ellinor, P. T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17374-3 · Cited by 459
Self-citationFrąk, W., Wojtasińska, A., Lisińska, W., Młynarska, E., Franczyk, B., & Rysz, J. (2022) · Biomedicines · doi:10.3390/biomedicines10081938 · Cited by 284
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation
Hoogeveen, R. C., & Ballantyne, C. M. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa252 · Cited by 322
Genetics of Common, Complex Coronary Artery Disease
Musunuru, K., & Kathiresan, S. (2019) · Cell · doi:10.1016/j.cell.2019.02.015 · Cited by 246
Self-citationOlezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk
Bergmark, B. A., Marston, N. A., Prohaska, T. A., Alexander, V. J., Zimerman, A., Moura, F. A., Murphy, S. A., Goodrich, E. L., Zhang, S., Gaudet, D., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2402309 · Cited by 214
Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
Ganda, O. P., Bhatt, D. L., Mason, R. P., Miller, M., & Boden, W. E. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.061 · Cited by 195
Contribution of remnant cholesterol to cardiovascular risk
Langsted, A., Madsen, C. M., & Nordestgaard, B. G. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13059 · Cited by 194
The dawn of a new era of targeted lipid-lowering therapies
Tokgözoğlu, L., & Libby, P. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab841 · Cited by 171
Saeed, A., Feofanova, E. V., Yu, B., Sun, W., Virani, S. S., Nambi, V., Coresh, J., Guild, C., Boerwinkle, E., Ballantyne, C. M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.050 · Cited by 176
Newman, C. B., Blaha, M. J., Boord, J. B., Cariou, B., Chait, A., Fein, H. G., Ginsberg, H. N., Goldberg, I. J., Murad, M. H., Subramanian, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa674 · Cited by 180
Balling, M., Afzal, S., Varbo, A., Langsted, A., Davey Smith, G., & Nordestgaard, B. G. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.610 · Cited by 175
Lipid-Lowering Agents: Targets Beyond PCSK9
Hegele, R. A., & Tsimikas, S. (2019) · Circulation Research · doi:10.1161/circresaha.118.313171 · Cited by 171
Unique roles of rare variants in the genetics of complex diseases in humans
Momozawa, Y., & Mizukami, K. (2021) · Journal of Human Genetics · doi:10.1038/s10038-020-00845-2 · Cited by 161
Inherited basis of visceral, abdominal subcutaneous and gluteofemoral fat depots
Agrawal, S., Wang, M., Klarqvist, M. D. R., Smith, K., Shin, J. H., Dashti, H., Diamant, N., Choi, S. H., Jurgens, S. J., Ellinor, P. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30931-2 · Cited by 154
Self-citationRemnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population
Varbo, A., & Nordestgaard, B. G. (2019) · Annals of Neurology · doi:10.1002/ana.25432 · Cited by 145
Advances in lipid-lowering therapy through gene-silencing technologies
Nordestgaard, B. G., Nicholls, S. J., Langsted, A., Ray, K. K., & Tybjærg‐Hansen, A. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2018.3 · Cited by 148
Fruchart, J.-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Després, J.-P., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0864-7 · Cited by 140
Self-citationAbsence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis
Aryal, B., Singh, A. K., Zhang, X., Varela, L., Rotllan, N., Goedeke, L., Chaube, B., Camporez, J.-P., Vatner, D. F., Horvath, T. L., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97918 · Cited by 127
Kaltoft, M., Langsted, A., & Nordestgaard, B. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa172 · Cited by 122
Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction
Doi, T., Langsted, A., & Nordestgaard, B. G. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.384 · Cited by 129
Wulff, A. B., Nordestgaard, B. G., & Tybjærg‐Hansen, A. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310473 · Cited by 113
Genetics of Triglycerides and the Risk of Atherosclerosis
Dron, J. S., & Hegele, R. A. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0667-9 · Cited by 114
Coronary Artery Disease Genetics Enlightened by Genome-Wide Association Studies
Kessler, T., & Schunkert, H. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.04.001 · Cited by 111
Self-citationTriglycerides and risk of atherosclerotic cardiovascular disease: An update
Farnier, M., Zeller, M., Masson, D., & Cottin, Y. (2021) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2020.11.006 · Cited by 115
Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families
Gormley, P., Kurki, M., Hiekkala, M. E., Veerapen, K., Häppölä, P., Mitchell, A. A., Lal, D., Palta, P., Surakka, I. L., Kaunisto, M. A., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.04.014 · Cited by 102
Structure of the lipoprotein lipase–GPIHBP1 complex that mediates plasma triglyceride hydrolysis
Birrane, G., Beigneux, A. P., Dwyer, B., Strack-Logue, B., Kristensen, K. K., Francone, O. L., Fong, L. G., Mertens, H. D. T., Pan, C. Q., Ploug, M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817984116 · Cited by 98
Hu, T., Wen, P., Shen, W., Liu, F., Li, Q., Erna, L., Liao, S., Wu, H., & Zou, Y. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.9b00205 · Cited by 88
Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
Keirns, B. H., Sciarrillo, C. M., Koemel, N. A., & Emerson, S. R. (2021) · Journal of Nutritional Science · doi:10.1017/jns.2021.73 · Cited by 86
Ruscica, M., Zimetti, F., Adorni, M. P., Sirtori, C. R., Lupo, M. G., & Ferri, N. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104653 · Cited by 85
Glicksberg, B. S., Johnson, K. W., & Dudley, J. T. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy114 · Cited by 84
Lotta, L. A., Stewart, I. D., Sharp, S. J., Day, F. R., Burgess, S., Luan, J., Bowker, N., Cai, L., Li, C., Wittemans, L. B. L., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2866 · Cited by 72
Panomics for Precision Medicine
Sandhu, C., Qureshi, A. P., & Emili, A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.11.001 · Cited by 76
Zheng, S., Tsao, P. S., & Pan, C. (2024) · Nature Communications · doi:10.1038/s41467-024-49921-7 · Cited by 73
Hypertriglyceridemia—causes, significance, and approaches to therapy
Santos-Baez, L. S., & Ginsberg, H. N. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00616 · Cited by 66
Ragino, Y. I., Stakhneva, E. M., Polonskaya, Y. V., & Kashtanova, E. V. (2020) · Biomolecules · doi:10.3390/biom10030374 · Cited by 70
Morelli, M. B., Chavez, C., & Santulli, G. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1707806 · Cited by 64
Kolovou, G. D., Watts, G. F., Mikhailidis, D. P., Pérez-Martínez, P., Mora, S., Bilianou, H., Panotopoulos, G., Katsiki, N., Ooi, T. C., Lopez-Miranda, J., et al. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190507110519 · Cited by 61
Triglycerides and residual risk
Vallejo‐Vaz, A. J., Corral, P., Schreier, L. E., & Ray, K. K. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000530 · Cited by 60
Electronic health records: the next wave of complex disease genetics
Wolford, B. N., Willer, C. J., & Surakka, I. L. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy081 · Cited by 56
Self-citationBjörnsson, E., Þorleifsson, G., Helgadóttir, A., Guðnason, Þ., Guðbjartsson, T., Andersen, K. K., Grétarsdóttir, S., Ólafsson, Í., Tragante, V., Ólafsson, Ó., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.2946 · Cited by 59
Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease
Heo, J. H., & Jo, S.-H. (2023) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e295 · Cited by 58
Hansen, S. E. J., Madsen, C. M., Varbo, A., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.08.016 · Cited by 59
Target Populations for Novel Triglyceride-Lowering Therapies
Nordestgaard, A. T., Tybjærg-Hansen, A., Mansbach, H., Kersten, S., Nordestgaard, B. G., & Rosenson, R. S. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.02.035 · Cited by 54
Arca, M., Borghi, C., Pontremoli, R., Ferrari, G. M. D., Colivicchi, F., Desideri, G., & Temporelli, P. L. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.11.001 · Cited by 54
Genetics of coronary artery disease in the light of genome-wide association studies
Schunkert, H., von Scheidt, M., Kessler, T., Stiller, B., Zeng, L., & Vilne, B. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1324-1 · Cited by 52
Self-citationTada, H., Nohara, A., & Kawashiri, M. (2018) · Nutrients · doi:10.3390/nu10111789 · Cited by 53
Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study
Thomas, D. G., Wei, Y., & Tall, A. R. (2020) · Journal of Lipid Research · doi:10.1194/jlr.p120001000 · Cited by 53
Human genetics and its impact on cardiovascular disease
Tada, H., Fujino, N., Hayashi, K., Kawashiri, M., & Takamura, M. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.09.005 · Cited by 57
Chait, A. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.02.010 · Cited by 50
Chaudhry, R., Viljoen, A., & Wierzbicki, A. S. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1480368 · Cited by 47
Johansen, M. Ø., Vedel‐Krogh, S., Nielsen, S. F., Afzal, S., Smith, G. D., & Nordestgaard, B. G. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315639 · Cited by 43
Emdin, C. A., Khera, A. V., Aragam, K. G., Haas, M. E., Chaffin, M. D., Klarin, D. M., Natarajan, P., Bick, A. G., Zekavat, S. M., Nomura, A., et al. (2018) · Diabetes · doi:10.2337/db18-0857 · Cited by 42
Self-citationInsulin upregulates betatrophin expression via PI3K/Akt pathway
Lu, P., Chen, X., Zhang, Z., Zhang, J., Yang, Y., Liu, Z., Xie, J., Shao, S., Zhou, X., Hu, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06052-y · Cited by 41
Johansen, M. Ø., Nielsen, S. F., Afzal, S., Vedel‐Krogh, S., Smith, G. D., & Nordestgaard, B. G. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa290 · Cited by 42
Emdin, C. A., Haas, M., Khera, A. V., Aragam, K. G., Chaffin, M. D., Jiang, L., Wei, W., Feng, Q., Karjalainen, J. M., Havulinna, A. S., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/594523 · Cited by 40
Self-citationThe Evolving Story of Triglycerides and Coronary Heart Disease Risk
Návar, A. M. (2019) · JAMA · doi:10.1001/jama.2018.20044 · Cited by 39
Opportunities and Challenges in Mendelian Randomization Studies to Guide Trial Design
O’Donnell, C. J., & Sabatine, M. S. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2863 · Cited by 39
Pathogenesis of premature coronary artery disease: Focus on risk factors and genetic variants
Wang, H., Liu, Z., Shao, J., Jiang, M., Lu, X.-C., Lin, L., Wang, L., Xu, Q., Zhang, H. S., Li, X., et al. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.11.003 · Cited by 45
The contribution of non-coding regulatory elements to cardiovascular disease
Villar, D., Frost, S., Deloukas, P., & Tinker, A. (2020) · Open Biology · doi:10.1098/rsob.200088 · Cited by 34
Remnant lipoproteins and atherosclerotic cardiovascular disease
Tada, H., Nohara, A., Inazu, A., Mabuchi, H., & Kawashiri, M.-A. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.12.014 · Cited by 37
Partnership, T. G. O. E. S., Li, Z., Wang, Z., Lee, M., Zenkel, M., Peh, K. L. E., Ozaki, M., Topouzis, F., Nakano, S., Chan, A. S. Y., et al. (2021) · JAMA · doi:10.1001/jama.2021.0507 · Cited by 36
Chang, C. L., García‐Arcos, I., Nyrén, R., Olivecrona, G., Kim, J. Y., Hu, Y., Agrawal, R. R., Murphy, A. J., Goldberg, I. J., & Deckelbaum, R. J. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310607 · Cited by 35
Silbernagel, G., Chen, Y., Li, H., Lemen, D., Wen, Y., Zhen, Y., Rief, M., Kleber, M. E., Delgado, G., Sarzynski, M. A., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.069272 · Cited by 30
Self-citationTranslating GWAS Findings to Novel Therapeutic Targets for Coronary Artery Disease
Shu, L., Blencowe, M., & Yang, X. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00056 · Cited by 31
Kristensen, K. K., Leth-Espensen, K. Z., Kumari, A., Grønnemose, A. L., Winther, A.-M. L., Young, S. G., & Ploug, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.702508 · Cited by 33
Multitrait GWAS to connect disease variants and biological mechanisms
Julienne, H., Laville, V., McCaw, Z. R., He, Z., Guillemot, V., Lasry, C., Ziyatdinov, A., Nerin, C., Vaysse, A., Lechat, P., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009713 · Cited by 35
Huang, J. V., Cárdenas, A., Colicino, E., Schooling, C. M., Rifas‐Shiman, S. L., Agha, G., Zheng, Y., Hou, L., Just, A. C., Litonjua, A. A., et al. (2018) · Epigenetics · doi:10.1080/15592294.2018.1543503 · Cited by 28
Understanding Hypertriglyceridemia: Integrating Genetic Insights
Alves, M., Laranjeira, F., & Correia‐da‐Silva, G. (2024) · Genes · doi:10.3390/genes15020190 · Cited by 35
Muro, F. M. D., Vogel, B., Sartori, S., Bay, B., Oliva, A., Feng, Y., Krishnan, P., Sweeny, J. M., Gitto, M., Smith, K. F., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf112 · Cited by 31
What Causes Premature Coronary Artery Disease?
Le, A., Peng, H., Golinsky, D., Scipio, M. D., Lali, R., & Paré, G. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01200-y · Cited by 33
Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice
Josefs, T., Basu, D., Vaisar, T., Arets, B., Kanter, J. E., Huggins, L.-A., Hu, Y., Liu, J., Clouet-Foraison, N., Heinecke, J. W., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.317458 · Cited by 28
Monogenic and Polygenic Models of Coronary Artery Disease
Muse, E. D., Chen, S.-F., & Torkamani, A. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01540-0 · Cited by 27
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies
Ray, K. K., Linnebjerg, H., Michael, L. F., Shen, X. P., Ma, X., Lim, S., Zhen, Y., Dudek, H., Abrams, M., Saxena, U. H., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.03.005 · Cited by 28
Ishihama, S., Yoshida, S., Yoshida, T., Mori, Y., Ouchi, N., Eguchi, S., Sakaguchi, T., Tsuda, T., Kato, K., Shimizu, Y., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100882r · Cited by 26
Advancing drug discovery using the power of the human genome
Heilbron, K., Mozaffari, S. V., Vacic, V., Yue, P., Wang, W., Shi, J., Jubb, A. M., Pitts, S. J., & Wang, X. (2021) · The Journal of Pathology · doi:10.1002/path.5664 · Cited by 25
Remnant cholesterol as a new lipid-lowering target to reduce cardiovascular events
Raggi, P., Becciu, M. L., & Navarese, E. P. (2024) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000921 · Cited by 25
Kumari, A., Grønnemose, A. L., Kristensen, K. K., Winther, A.-M. L., Young, S. G., Jørgensen, T. J. D., & Ploug, M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2221888120 · Cited by 24
Taskinen, M., Matikainen, N., Björnson, E., Söderlund, S., Inkeri, J., Hakkarainen, A., Parviainen, H., Sihlbom, C., Thorsell, A., Andersson, L. K., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-06008-0 · Cited by 23
Chang, C. L. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000536 · Cited by 23
Genomics of hypertriglyceridemia
Tada, H., Takamura, M., & Kawashiri, M. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.12.005 · Cited by 22
Personalized medicine in cardiovascular disease: review of literature
Sheikhy, A., Fallahzadeh, A., Meybodi, H. R. A., Hasanzad, M., Tajdini, M., & Hosseini, K. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00840-0 · Cited by 20
Genome-wide discovery for biomarkers using quantile regression at biobank scale
Wang, C., Wang, T., Kiryluk, K., Wei, Y., Aschard, H., & Ionita‐Laza, I. (2024) · Nature Communications · doi:10.1038/s41467-024-50726-x · Cited by 20
Khan, S. U., Saeed, S., Alsuhaibani, A. M., Fatima, S., Rehman, K. U., Zaman, U., Ullah, M., Refat, M. S. E.-D., & Lu, K. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101821 · Cited by 19
Triglyceride-Rich Lipoproteins
Kockx, M., & Kritharides, L. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2017.12.008 · Cited by 20
Modder, M., Panhuis, W. I. H., Li, M., Afkir, S., Dorn, A. L., Pronk, A. C. M., Streefland, T. C. M., Lalai, R. A., Pierrou, S. E., Nilsson, S. K., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae195 · Cited by 17
Li, H., Liu, G., Wan, X., Zhou, L., Qin, Z., Ma, X., Su, K., Liu, Y., Yuan, J., Wei, C., et al. (2021) · Hepatology · doi:10.1002/hep.32176 · Cited by 18
Lipoprotein Lipase: Structure, Function, and Genetic Variation
Perera, S. D., Wang, J., McIntyre, A. D., & Hegele, R. A. (2025) · Genes · doi:10.3390/genes16010055 · Cited by 17
Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
Tada, H., Yeo, K. K., Li, J., Tan, K. C. B., Ako, J., Krittayaphong, R., Tan, R., Aylward, P. E., Lam, C. S. P., Baek, S. H., et al. (2021) · JACC Asia · doi:10.1016/j.jacasi.2021.08.008 · Cited by 15
Bergmark, B. A., Marston, N., Prohaska, T. A., Alexander, V. J., Zimerman, A., Moura, F. A., Kang, Y. M., Murphy, S. A., Zhang, S. M., Lu, M. T., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.02.022 · Cited by 15
Shaik, A., & Rosenson, R. S. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07168-0 · Cited by 15
Konjac Glucomannan Attenuated Triglyceride Metabolism during Rice Gruel Tolerance Test
Nagasawa, T., Kimura, T., Yoshida, A., Tsunekawa, K., Araki, O., Ushiki, K., Ishigaki, H., Shoho, Y., Suda, I., Hiramoto, S., et al. (2021) · Nutrients · doi:10.3390/nu13072191 · Cited by 15
Large-Scale Genomic Biobanks and Cardiovascular Disease
Small, A., O’Donnell, C. J., & Damrauer, S. M. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0969-8 · Cited by 16
Zhu, J., Zhang, X., Chen, X., Sun, Y., Dai, Y., Chen, C., Zhang, T., & Yan, Z. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.012 · Cited by 14
The genetic basis of sudden death in young people – Cardiac and non-cardiac
Li, F., Yin, P., & Xu, Z. (2021) · Gene · doi:10.1016/j.gene.2021.146067 · Cited by 14
Metadata
- Authors
- Khera, A. V., Won, H.-H., Peloso, G. M., O’Dushlaine, C., Liu, D., Stitziel, N. O., Natarajan, P., Nomura, A., Emdin, C. A., Gupta, N., Borecki, I. B., Asselta, R., Duga, S., Merlini, P. A., Correa, A., Kessler, T., Wilson, J. G., Bown, M. J., Hall, A. S., Braund, P. S., Carey, D. J., Murray, M. F., Kirchner, H. L., Leader, J. B., Lavage, D. R., Manus, J. N., Hartzel, D. N., Samani, N. J., Schunkert, H., Marrugat, J., Elosua, R., McPherson, R., Farrall, M., Watkins, H., Lander, E. S., Rader, D. J., Danesh, J., Ardissino, D., Gabriel, S., Willer, C., Abecasis, G. R., Saleheen, D., Dewey, F. E., Kathiresan, S., & for the Myocardial Infarction Genetics Consortium, D. S. G.
- Affiliations
- Broad Institute (US)
- Samsung Medical Center (KR)
- Regeneron (United States) (US)
- Pennsylvania State University (US)
- Washington University in St. Louis (US)
- Humanitas University (IT)
- Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
- University of Mississippi Medical Center (US)
- German Centre for Cardiovascular Research (DE)
- University of Leicester (GB)
- University of Leeds (GB)
- Geisinger Health System (US)
- Hospital del Mar Research Institute (ES)
- Cardiovascular Epidemiology and Genetics, Hospital del Mar Research Institute, Barcelona, Spain
- University of Ottawa (CA)
- Centre for Human Genetics (GB)
- University of Pennsylvania (US)
- University of Cambridge (GB)
- University of Parma (IT)
- University of Michigan (US)
- Corresponding author
- Kathiresan, Sekar
- ORCID
- Khera, Amit V.
- Won, Hong-Hee
- Peloso, Gina M.
- O’Dushlaine, Colm
- Liu, Dajiang
- Stitziel, Nathan O.
- Natarajan, Pradeep
- Nomura, Akihiro
- Emdin, Connor A.
- Gupta, Namrata
- Borecki, Ingrid B.
- Asselta, Rosanna
- Duga, Stefano
- Correa, Adolfo
- Kessler, Thorsten
- Wilson, James G.
- Bown, Matthew J.
- Hall, Alistair S.
- Braund, Peter S.
- Carey, David J.
- Murray, Michael F.
- Kirchner, H. Lester
- Leader, Joseph B.
- Lavage, Daniel R.
- Hartzel, Dustin N.
- Samani, Nilesh J.
- Schunkert, Heribert
- Marrugat, Jaume
- McPherson, Ruth
- Farrall, Martin
- Watkins, Hugh
- Lander, Eric S.
- Rader, Daniel J.
- Danesh, John
- Ardissino, Diego
- Gabriel, Stacey
- Willer, Cristen
- Abecasis, Gonçalo R.
- Saleheen, Danish
- Kathiresan, Sekar
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2017-03-07
- Volume
- 317
- Issue
- 9
- Pages
- 937
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC5664181
- OpenAlex
- W2594391902
- Cited by
- 198
- References
- 46
- Citations by year
- 2026: 11 · 2025: 23 · 2024: 18 · 2023: 15 · 2022: 15 · 2021: 26 · 2020: 29 · 2019: 18 · 2018: 29 · 2017: 13
- FWCI
- 18.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Apollo
- Funders
- University of Pennsylvania
- Pennsylvania State University
- University of Ottawa
- Regeneron Pharmaceuticals
- Wellcome Trust (090532/Z/09/Z)
- School of Public Health, University of Michigan
- National Institute for Health and Care Research (NF-SI-0512-10165)
- British Heart Foundation (MR/L003120/1, CS/14/2/30841, RE/13/1/30181, RG/13/13/30194, RG/08/014/24067)
- University of Leicester
- University of Oxford
- University of Leeds
- Technische Universität München
- Humanitas University
- National Institutes of Health (1rc2hl103010-01, KL2TR001100)
- Samsung
- Perelman School of Medicine, University of Pennsylvania
- Penn State College of Medicine
- Medical Research Council (MR/L01629X/1, MR/L003120/1)
- National Heart, Lung, and Blood Institute (HHSN268201300050C, R01HL127564, RC2HL102925, HHSN268201300046C, K08HL114642, RC2HL102926, RC2HL102923, HHSN268201300048C, RC2HL-103010, HHSN268201300049C, R35HL135824, K01HL125751, RC2HL102924, HHSN268201300047C, R01HL109946, R01HL131961)
- National Human Genome Research Institute (U54HG003067)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- lipoprotein lipase, LPL gene, coronary artery disease, premature coronary artery disease, rare variants, loss-of-function mutations, missense mutations, common genetic variants, plasma triglycerides, lipoprotein lipase deficiency, genetic association, serum lipids
- MeSH terms
- Adult, Coronary Artery Disease, Cross-Sectional Studies, Female, Genotype, Heterozygote, Humans, Lipoprotein Lipase, Lipoproteins, Male, Middle Aged, Mutation, Triglycerides, Odds Ratio, Case-Control Studies, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
